Stockscreener 앱 받기
23.70
2.95%
-0.72
시간 외 거래:
23.84
0.14
+0.59%
전일 마감가:
$24.42
열려 있는:
$24.38
하루 거래량:
2.54M
Relative Volume:
0.67
시가총액:
$17.61B
수익:
$956.00K
순이익/손실:
$-221.32M
주가수익비율:
-74.06
EPS:
-0.32
순현금흐름:
$-142.25M
1주 성능:
-9.54%
1개월 성능:
-11.37%
6개월 성능:
+28.18%
1년 성능:
+84.29%
1일 변동 폭
$23.63
$24.42
1주일 범위
$23.63
$30.05
52주 변동 폭
$11.76
$36.91
Summit Therapeutics Inc Stock (SMMT) Company Profile
명칭
Summit Therapeutics Inc
전화
305-203-2034
주소
601 BRICKELL KEY DRIVE, MIAMI
SMMT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SMMT
Summit Therapeutics Inc
|
23.70 | 18.14B | 956.00K | -221.32M | -142.25M | -0.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Summit Therapeutics Inc Stock (SMMT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-19 | 개시 | Piper Sandler | Neutral |
| 2025-07-01 | 개시 | UBS | Buy |
| 2025-06-11 | 개시 | Leerink Partners | Underperform |
| 2025-03-26 | 업그레이드 | Citigroup | Neutral → Buy |
| 2025-03-21 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-03-12 | 개시 | Evercore ISI | Outperform |
| 2025-02-28 | 개시 | Goldman | Buy |
| 2025-01-08 | 개시 | Truist | Buy |
| 2024-12-11 | 개시 | Wells Fargo | Overweight |
| 2024-12-06 | 개시 | Jefferies | Buy |
| 2024-11-04 | 개시 | JMP Securities | Mkt Outperform |
| 2024-09-27 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-08-12 | 개시 | H.C. Wainwright | Buy |
| 2024-05-07 | 개시 | Citigroup | Buy |
| 2024-03-26 | 개시 | Stifel | Buy |
| 2018-06-28 | 다운그레이드 | Janney | Buy → Neutral |
| 2018-05-02 | 개시 | Janney | Buy |
| 2018-04-12 | 재확인 | Needham | Buy |
| 2018-02-13 | 개시 | BTIG Research | Buy |
| 2018-01-04 | 개시 | SunTrust | Buy |
| 2017-12-01 | 재개 | H.C. Wainwright | Buy |
| 2016-11-16 | 재확인 | RBC Capital Mkts | Outperform |
| 2016-10-05 | 재확인 | Needham | Buy |
| 2016-09-16 | 개시 | H.C. Wainwright | Buy |
| 2015-03-30 | 개시 | Needham | Buy |
| 2015-03-30 | 개시 | Oppenheimer | Outperform |
모두보기
Summit Therapeutics Inc 주식(SMMT)의 최신 뉴스
What are Summit Therapeutics Inc.’s recent SEC filings showingJuly 2025 Volume & AI Driven Price Predictions - خودرو بانک
Update Recap: Should you avoid Summit Therapeutics Inc. stock right nowJuly 2025 PostEarnings & Verified Swing Trading Watchlists - خودرو بانک
Will Summit Therapeutics Inc. benefit from AI trendsWeekly Profit Report & Risk Controlled Swing Alerts - خودرو بانک
Can Summit Therapeutics Inc. recover in the next quarterWeekly Trading Summary & Weekly Return Optimization Plans - Newser
How to build a dashboard for Summit Therapeutics Inc. stockJuly 2025 Patterns & Expert Curated Trade Setups - Newser
Exit strategy if you’re trapped in Summit Therapeutics Inc.July 2025 Closing Moves & Daily Momentum Trading Reports - Newser
Insider Stock Buying Reaches US$78.0m On Summit Therapeutics - 富途牛牛
Applying Wyckoff theory to Summit Therapeutics Inc. stock2025 Market Outlook & Real-Time Market Trend Scan - Newser
What’s next for Summit Therapeutics Inc. stock priceSwing Trade & Accurate Intraday Trading Signals - Newser
Applying big data sentiment scoring on Summit Therapeutics Inc.Trade Exit Report & Growth Focused Entry Reports - Newser
How hedge fund analytics apply to Summit Therapeutics Inc. stockJuly 2025 Trade Ideas & Safe Swing Trade Setup Alerts - Newser
How high can Summit Therapeutics Inc. stock goJuly 2025 Closing Moves & Safe Swing Trade Setup Alerts - Newser
Is Summit Therapeutics Inc. stock poised for growthTrade Risk Assessment & Verified Swing Trading Watchlists - Newser
Using RSI to spot recovery in Summit Therapeutics Inc.Market Growth Summary & Free Weekly Chart Analysis and Trade Guides - Newser
Published on: 2025-08-31 13:18:53 - Newser
Heatmap analysis for Summit Therapeutics Inc. and competitorsJuly 2025 Sector Moves & Fast Entry and Exit Trade Plans - Newser
Is Summit Therapeutics Inc. trending in predictive chart modelsGlobal Markets & High Return Stock Watch Alerts - Newser
Top chart patterns to watch in Summit Therapeutics Inc.July 2025 Pullbacks & Real-Time Chart Pattern Alerts - Newser
Using flow based indicators on Summit Therapeutics Inc.Weekly Stock Analysis & Real-Time Buy Zone Alerts - Newser
3 No-Brainer Stocks to Buy Right Now - The Globe and Mail
Analyzing Summit Therapeutics Inc. with multi timeframe chartsWeekly Trade Report & Long-Term Growth Stock Strategies - Newser
Summit Therapeutics Inc. stock trend outlook and recovery pathJuly 2025 PreEarnings & Precise Buy Zone Identification - Newser
How to read the order book for Summit Therapeutics Inc.Risk Management & Real-Time Buy Signal Alerts - Newser
H.C. Wainwright Lifts PT on Summit Therapeutics (SMMT) to $50 From $44 - Yahoo Finance
Smart tools for monitoring Summit Therapeutics Inc.’s price actionEarnings Growth Report & Risk Adjusted Buy/Sell Alerts - Newser
What to expect from Summit Therapeutics Inc. in the next 30 daysWeekly Loss Report & Free Real-Time Market Sentiment Alerts - Newser
Visual trend scoring systems applied to Summit Therapeutics Inc.Quarterly Growth Report & Long-Term Capital Growth Ideas - Newser
SVP, US Marketing at Summit Therapeutics Inc. Job - Mediabistro
Biotech Sector Stocks Witnessing Increased Search Activity - AInvest
Candlestick Signal Suggests Reversal in Summit Therapeutics Inc.July 2025 Big Picture & Verified Chart Pattern Trade Signals - beatles.ru
Summit Therapeutics Inc. Breaks Below Key Support LevelMarket Activity Recap & Weekly High Return Stock Forecasts - beatles.ru
Using data filters to optimize entry into Summit Therapeutics Inc.Rate Hike & Daily Growth Stock Investment Tips - Newser
Summit Therapeutics Inc (SMMT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Summit Therapeutics Inc 주식 (SMMT) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| DUGGAN ROBERT W | Co-Chief Executive Officer |
May 30 '25 |
Option Exercise |
2.64 |
74,545 |
196,799 |
555,754,696 |
1.09%
0.96%
자본화:
|
볼륨(24시간):